Profil
Usama Malik est directeur financier et commercial chez Immunomedics, Inc. Dans sa carrière précédente, M. Malik a occupé le poste de vice-président mondial chargé de la stratégie et de l'innovation chez Pfizer Inc. Il a obtenu un diplôme de premier cycle à l'université du Maryland et un MBA à l'INSEAD.
Anciens postes connus de Usama Malik
| Sociétés | Poste | Fin |
|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Chief Executive Officer | 02/12/2021 |
| IMMUNOMEDICS, INC. | Director of Finance/CFO | 01/12/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/11/2011 |
Formation de Usama Malik
| INSEAD | Masters Business Admin |
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
